–
Oruka Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.3
FY22:
−10.6
FY23:
−7.30
FY24:
−88.1
FY25:
−122
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−105
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.3
FY22:
–
FY23:
–
FY24:
−83.7
FY25:
−105
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.3
FY22:
−9.93
FY23:
−5.34
FY24:
−83.7
FY25:
−105
All amounts in millions USD